Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Mar;22(1):59-63.
doi: 10.4103/0974-9233.148350.

Adherence to topical glaucoma medications in Ethiopian patients

Lemlem Tamrat  1 , Girum W Gessesse  2 , Yeshigeta Gelaw  2
Affiliations

Adherence to topical glaucoma medications in Ethiopian patients

Lemlem Tamrat et al. Middle East Afr J Ophthalmol. 2015 Jan-Mar.

Abstract

Purpose: Successful outcomes of medical treatment for glaucoma require proper and daily use of medication to prevent disease progression. The aim of this study was to determine the adherence to anti-glaucoma medications and factors associated with non-adherence among patients with ocular hypertension (OHT) or glaucoma at Jimma University Specialized Hospital, Ethiopia.

Materials and methods: A hospital based cross sectional study was conducted on 200 consecutive patients from July to November 2010 at Jimma University Hospital in Southwest Ethiopia. Patients with OHT or glaucoma who were taking topical anti-glaucoma medications for more than six months were included. The study subjects were interviewed and their medical records were reviewed. Non-adherence to glaucoma therapy (NAGT) was defined as self-reported on missed medications or missed appointments, or a physician noting poor adherence. A P < 0.05 was statistically significant.

Result: Overall, 135 (67.5%) patients were non adherent to glaucoma therapy. Non adherence was associated with older age (P = 0.04), advanced stage of glaucoma (P = 0.01), longer frequency of follow up (P = 0.00) and financial problem (P = 0.000). Sex (P = 0.53), level of education (P = 0.09), and marital status (P = 0.77) were not statistically significantly associated with non-adherence to anti-glaucoma drug treatment.

Conclusion: A relatively high proportion of patients were not adhering to the medications regimen for glaucoma. Older age, advanced glaucoma, lengthier frequency of follow-up and financial hardship were associated with non-adherence. Eye care providers should be aware of the problem of non-adherence to topical medications.

Keywords: Adherence; Ethiopia; Glaucoma; Ocular Hypertension; Topical Glaucoma Therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82:887–8. - PMC - PubMed
    1. Zerihun N, Mabey D. Blindness and low vision in Jimma Zone, Ethiopia: Results of a population-based survery. Ophthalmic Epidemiol. 1997;4:19–26. - PubMed
    1. Kass MA, Heuer DK, Higginbotham EJ, et al. Ocular hypertension Treatment Study Group. A randomized trial determines that topical hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmology. 2002;120:701–13. - PubMed
    1. Heijl A, Leske MC, Bengtsson B, et al. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmology. 2002;120:1268–79. - PubMed
    1. WHO Library Cataloguing-in-Publication Data. World Health Organization; 2003. Adherence to long-term therapies: Evidence for action.

MeSH terms

Substances